Sarah Fernandes Teixeira

CV Lattes ResearcherID Google Scholar Citations

Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

PhD (pharmacology) by the Institute of Biomedical Sciences of University of São Paulo (2020). She is a pharmacist (Federal University of Espírito Santo in 2013), and during this period, from 2011 to 2013, she participated, as an undergraduate student, in a scientific research group which the focus was researching new naphthoquinones with antiproliferative activity and therapeutic combinations of antineoplastic agents with metformin in non-small cell lung cancer treatment. She worked, during her master and PhD projects, in projects screening new anticancer drugs in vitro and in vivo, characterizing the mechanisms of action of these novel anticancer agents. Currently she is a teacher of UNESC and reviewer of PLOS ONE (ISSN 1932-6203) and UNESC em Revista (ISSN 2527-0168). (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Completed (most recent)

Abstract
Lung cancer is a challenge to public health because of its high incidence and mortality in the world. Thus, it is urgent to search for new therapies for its treatment. The intervention of the metabolism of phospholipids, specially for phosphatidylethanolamine (PE), has an important potential for the development of new treatment strategies for lung cancer. The PE is a major component of ce…
Validation of CTP:phosphoethanolamine cytidylyltransferase enzyme and ethanolamine transport as new targets for the rational development of new drugs in Non-Small Cell Lung Cancer treatment, BP.DR
Abstract
Lung cancer is one of the most incident and lethal cancers in Brazil and all over the world, thus, the pursuit for new drugs to control this disease is necessary. Among the tumor cellular changes there are the high proliferative activity level and the consequent cellular membrane continuous and increased genesis. Consistently, certain phospholipids, such as miltefosine, that can disrupt t…
Evaluation of the activity of CHY-1, a novel miltefosine analogue, as a potential CTP: phosphoethanolamine cytidylyltransferase enzyme inhibitor, against non-small cell lung câncer, BP.MS

Virtual Library in numbers * Updated data on August 16, 2025

Total / Available in English

2 / 2	Completed scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Emer Suavinho Ferro

Keywords used by the researcher

Biological Sciences Pharmacology

Please report errors on the page using this form.

Short URL

Abstract

Abstract